Debasis Dash

Title: Debasis Dash: Innovator in Computational Drug Target Identification

Introduction

Debasis Dash is a prominent inventor based in Delhi, India. He has made significant contributions to the field of computational biology, particularly in the identification of potential drug targets. His innovative approach combines computational methods with biological data to enhance drug discovery processes.

Latest Patents

Debasis Dash holds a patent for a "Computer based method for identifying peptides useful as drug targets." This invention relates to a novel computational method that performs genome-wise comparisons of various organisms. The method involves creating peptide libraries from protein sequences and comparing them to identify conserved invariant peptide motifs. This approach has led to the identification of several invariant peptide motifs through direct sequence comparison between bacterial organisms and host genomes. The method is particularly useful for identifying potential drug targets and can serve as a drug screening tool for broad-spectrum antibacterials, as well as for specific diagnosis of infections. Additionally, it aids in assigning functions to proteins of unknown functions using invariant peptide motif signatures.

Career Highlights

Debasis Dash is associated with the Council of Scientific and Industrial Research, where he continues to work on innovative projects that bridge the gap between computational methods and biological applications. His research has the potential to impact the fields of drug discovery and infectious disease diagnosis significantly.

Collaborations

One of his notable collaborators is Samir Kumar Brahmachari, with whom he has worked on various research initiatives aimed at advancing the understanding of peptide motifs and their applications in drug development.

Conclusion

Debasis Dash's contributions to the field of computational biology exemplify the intersection of technology and medicine. His innovative methods for identifying drug targets are paving the way for advancements in antibacterial treatments and diagnostics.